title: Molecular diversity and population structure at the Cytochrome P450 3A5 gene in Africa.
abstract: BACKGROUND
  Cytochrome P450 3A5 (CYP3A5) is an enzyme involved in the metabolism of many therapeutic drugs. CYP3A5 expression levels vary between individuals and populations, and this contributes to adverse clinical outcomes. Variable expression is largely attributed to four alleles, CYP3A5*1 (expresser allele); CYP3A5*3 (rs776746), CYP3A5*6 (rs10264272) and CYP3A5*7 (rs41303343) (low/non-expresser alleles). Little is known about CYP3A5 variability in Africa, a region with considerable genetic diversity. Here we used a multi-disciplinary approach to characterize CYP3A5 variation in geographically and ethnically diverse populations from in and around Africa, and infer the evolutionary processes that have shaped patterns of diversity in this gene. We genotyped 2538 individuals from 36 diverse populations in and around Africa for common low/non-expresser CYP3A5 alleles, and re-sequenced the CYP3A5 gene in five Ethiopian ethnic groups. We estimated the ages of low/non-expresser CYP3A5 alleles using a linked microsatellite and assuming a step-wise mutation model of evolution. Finally, we examined a hypothesis that CYP3A5 is important in salt retention adaptation by performing correlations with ecological data relating to aridity for the present day, 10,000 and 50,000 years ago.
  
  
  RESULTS
  We estimate that ~43% of individuals within our African dataset express CYP3A5, which is lower than previous independent estimates for the region. We found significant intra-African variability in CYP3A5 expression phenotypes. Within Africa the highest frequencies of high-activity alleles were observed in equatorial and Niger-Congo speaking populations. Ethiopian allele frequencies were intermediate between those of other sub-Saharan African and non-African groups. Re-sequencing of CYP3A5 identified few additional variants likely to affect CYP3A5 expression. We estimate the ages of CYP3A5*3 as ~76,400 years and CYP3A5*6 as ~218,400 years. Finally we report that global CYP3A5 expression levels correlated significantly with aridity measures for 10,000 [Spearmann's Rho= -0.465, p=0.004] and 50,000 years ago [Spearmann's Rho= -0.379, p=0.02].
  
  
  CONCLUSIONS
  Significant intra-African diversity at the CYP3A5 gene is likely to contribute to multiple pharmacogenetic profiles across the continent. Significant correlations between CYP3A5 expression phenotypes and aridity data are consistent with a hypothesis that the enzyme is important in salt-retention adaptation.
authors: Research Department of Genetics, Evolution and Environment, University College London, Darwin Building, Gower Street, London, WC1E 6BT, UK. r.bains@ucl.ac.uk
authors: Ripudaman K
authors: RK
authors: Bains
authors: Mirna
authors: M
authors: Kovacevic
authors: Christopher A
authors: CA
authors: Plaster
authors: Ayele
authors: A
authors: Tarekegn
authors: Endashaw
authors: E
authors: Bekele
authors: Neil N
authors: NN
authors: Bradman
authors: Mark G
authors: MG
authors: Thomas
mesh_terms: D000349:Africa; D000483:Alleles; D051544:Cytochrome P-450 CYP3A / Q000235:genetics*; D014644:Genetic Variation; D005828:Genetics, Population; D006801:Humans; D010641:Phenotype
chemical_list: C510164:CYP3A5 protein, human; D051544:Cytochrome P-450 CYP3A
references: PLoS Genet. 2005 Dec;1(6):e82
references: 16429165
references: Nat Biotechnol. 2012 Feb 08;30(2):126
references: 22318022
references: Science. 2008 Feb 22;319(5866):1100-4
references: 18292342
references: Am J Hum Genet. 2001 Apr;68(4):978-89
references: 11254454
references: Mol Biol Evol. 2004 May;21(5):936-44
references: 15014171
references: Mol Pharmacol. 2005 Sep;68(3):808-15
references: 15955870
references: Nat Genet. 2006 Nov;38(11):1251-60
references: 17057719
references: Arch Biochem Biophys. 1989 Nov 1;274(2):355-65
references: 2802615
references: Cancer Lett. 2005 Jan 10;217(1):61-72
references: 15596297
references: Nature. 2001 Feb 15;409(6822):758-60
references: 11236971
references: J Comput Biol. 1996 Winter;3(4):479-502
references: 9018600
references: Xenobiotica. 2006 Dec;36(12):1191-200
references: 17162466
references: Drug Metab Rev. 2009;41(2):89-295
references: 19514967
references: Cancer Epidemiol Biomarkers Prev. 2003 Sep;12(9):928-32
references: 14504207
references: Ther Drug Monit. 2004 Apr;26(2):192-9
references: 15228164
references: Adv Drug Deliv Rev. 2002 Nov 18;54(10):1271-94
references: 12406645
references: Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16057-62
references: 19706453
references: Clin Pharmacol Ther. 2007 May;81(5):708-12
references: 17329995
references: Bioinformatics. 2009 Jun 1;25(11):1451-2
references: 19346325
references: Genetics. 2000 Jul;155(3):1405-13
references: 10880498
references: Am J Hum Genet. 2002 May;70(5):1197-214
references: 11910562
references: Pharmacogenet Genomics. 2010 Nov;20(11):647-64
references: 20881513
references: Curr Biol. 2005 Mar 8;15(5):R159-60
references: 15753023
references: Clin Pharmacol Ther. 2005 May;77(5):373-87
references: 15900284
references: Philos Trans R Soc Lond B Biol Sci. 2011 Mar 27;366(1566):863-77
references: 21320900
references: Hum Genet. 2005 Aug;117(4):366-75
references: 15928903
references: Trends Genet. 2006 Aug;22(8):437-46
references: 16808986
references: Am J Hum Genet. 2003 Oct;73(4):768-79
references: 13680527
references: Hum Mutat. 2001 Aug;18(2):87-100
references: 11462233
references: Genetics. 2003 Jun;164(2):781-7
references: 12807796
references: Expert Opin Drug Metab Toxicol. 2010 Jan;6(1):17-28
references: 19968573
references: Bioinformatics. 2005 Jul 1;21(13):2933-42
references: 15860560
references: Ann Hum Genet. 2005 May;69(Pt 3):275-87
references: 15845032
references: J Hypertens. 2006 May;24(5):923-9
references: 16612255
references: Ann Hum Genet. 2011 Mar;75(2):236-46
references: 21309756
references: Hum Genet. 1999 Dec;105(6):577-81
references: 10647892
references: PLoS Biol. 2006 Mar;4(3):e72
references: 16494531
references: J Biol Chem. 1989 Jun 25;264(18):10388-95
references: 2732228
references: J Appl Physiol (1985). 2003 Sep;95(3):1297-300
references: 12754175
references: Science. 2006 Jun 16;312(5780):1614-20
references: 16778047
references: Nat Genet. 2001 Apr;27(4):383-91
references: 11279519
references: Ther Drug Monit. 2010 Jun;32(3):346-52
references: 20357698
references: Pharmacogenomics J. 2011 Apr;11(2):130-7
references: 20231858
references: Evol Bioinform Online. 2007 Feb 23;1:47-50
references: 19325852
references: Lancet. 1998 Apr 18;351(9110):1208
references: 9643720
references: J Clin Pharm Ther. 2008 Feb;33(1):61-5
references: 18211618
references: Pharmacogenetics. 2003 Aug;13(8):461-72
references: 12893984
references: Pharmacogenetics. 2001 Dec;11(9):773-9
references: 11740341
references: Am J Hum Genet. 2004 Dec;75(6):1059-69
references: 15492926
references: Drug Metab Dispos. 2005 Jul;33(7):884-7
references: 15833928
references: Nat Genet. 2007 Jan;39(1):31-40
references: 17159977
references: Proc Biol Sci. 2012 Nov 7;279(1746):4305-21
references: 22933370
references: Am J Hum Genet. 2000 Feb;66(2):651-8
references: 10677323
references: J Comput Biol. 1997 Fall;4(3):311-23
references: 9278062
references: Am J Hum Genet. 2012 Jul 13;91(1):83-96
references: 22726845
references: Pharmacogenomics. 2009 Mar;10(3):477-87
references: 19290795
references: Lancet. 2002 Oct 12;360(9340):1155-62
references: 12387968
references: Am J Hum Genet. 2004 Nov;75(5):752-70
references: 15457403
references: Science. 2007 Nov 16;318(5853):1074-5
references: 18006727
references: Nat Methods. 2010 Apr;7(4):248-9
references: 20354512
references: Genetics. 1995 Jan;139(1):457-62
references: 7705646
references: Environ Health Perspect. 2009 Oct;117(10):1541-8
references: 20019904
references: Proc Natl Acad Sci U S A. 1995 Jul 18;92(15):6723-7
references: 7624310
references: Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):15942-7
references: 16243969
references: Pharmacogenet Genomics. 2008 Oct;18(10):877-86
references: 18794725
references: Mol Pharmacol. 2002 Jul;62(1):162-72
references: 12065767
references: J Biol Chem. 2004 Sep 10;279(37):38379-85
references: 15252010
references: Am J Hum Genet. 2002 Nov;71(5):1082-111
references: 12395296
references: Lancet. 2010 May 1;375(9725):1497-8
references: 20435212
references: Gastroenterology. 2010 May;138(5):1653-4
references: 20332044
references: Gene. 2013 Jan 10;512(2):226-31
references: 23107770
references: Annu Rev Genomics Hum Genet. 2000;1:225-49
references: 11701630
references: Bioinformatics. 2004 Jan 22;20(2):289-90
references: 14734327
references: Mol Pharmacol. 1990 Aug;38(2):207-13
references: 2385232
references: Sci Am. 1979 Nov;241(5):98-100, 102, 108 passim
references: 504979
references: Pharmacogenomics J. 2006 Mar-Apr;6(2):105-14
references: 16314882
references: Hum Mol Genet. 2011 Feb 1;20(3):528-40
references: 21081654
references: Am J Hum Genet. 1998 May;62(5):1260-2
references: 9545399
references: Pharmacogenomics. 2009 Sep;10(9):1413-22
references: 19761365